Neoadjuvant and adjuvant immunotherapy in early-stage non-small cell lung cancer

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - Taylor & Francis
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …
被引用次数：26 相关文章

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - search.proquest.com
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …
[HTML] nih.gov

[HTML][HTML] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - ncbi.nlm.nih.gov
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - Lung Cancer (Auckland, NZ), 2021 - pubmed.ncbi.nlm.nih.gov
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer.

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - go.gale.com
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …
[PDF] iupui.edu

[PDF][PDF] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - 2021 - scholarworks.iupui.edu
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer.

N Shukla, N Hanna - Lung Cancer (Auckland, NZ), 2021 - europepmc.org
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …
[HTML] dovepress.com

[HTML][HTML] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - dovepress.com
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - 2021 - scholarworks.iupui.edu
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer

N Shukla, N Hanna - Lung Cancer: Targets and Therapy, 2021 - dovepress.com
Surgery or concurrent chemoradiation are standard of care treatments for patients with
localized and locally advanced non-small cell lung cancer (NSCLC). While resection and …